Protein released by C. burnetti interacts with antioxidising enzyme GPX4 to prevent cell damage and death.
List view / Grid view
Researchers have discovered a way to ignite T cells, potentially increasing the scope and success of T cell-based immunotherapy.
New research has found that microbial fermentation of dietary fibre in the gut can protect against allergic skin diseases.
Scientists have developed a metal-organic framework that, when attached to antibodies, improved their targeted delivery in in vitro studies.
A team has characterised a key part of the peptide synthesis process, showing that only the main building block needs to be changed for re-engineering.
Researchers have used cryo-EM to show that a new nanobody cocktail can bind to the S protein of SARS-CoV-2, neutralising the coronavirus.
Scientists have created the first model of early human embryos by reprogramming fibroblasts into a blastocyst-like structures.
A key process in β-cell regeneration has been discovered by researchers who say this could lead to improved treatments for diabetes.
In a zebrafish model, researchers have found that the protein NAPMT can trigger muscle stem cells to proliferate and heal muscle damage.
Researchers have discovered that giving L-tyrosine and PCS to mice prevents lung inflammation and an allergic asthma response.
Researchers have developed a new self-assembling three-dimensional (3D) ovarian cancer tumour model to recreate the in vitro disease more accurately.
A novel drug has been created which prevented the blood clotting associated with heart attacks and strokes in pre-clinical studies.
New research indicates COVID-19 could trigger the development of diabetes in healthy people, prompting experts to establish a registry for COVID-19 and diabetes data.